Glaxo, UK
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- ZANTAC solution for injection 50 mg/2 ml
- D01 - Antifúngicos para uso dermatológico
- GRISOVIN tablet 125 mg
- GRISOVIN tablet 500 mg
- D07 - Preparados dermatológicos con corticosteroides
- BETNOVATE C cream
- BETNOVATE C ointment
- BETNOVATE cream 0.1%
- BETNOVATE N cream
- BETNOVATE N cutaneous liquid
- BETNOVATE N ointment
- BETNOVATE ointment 0.1%
- CUTIVATE cream 0.05%
- CUTIVATE ointment 0.005%
- DERMOVATE NN cream 0.05%
- H03 - Terapia tiroidea
- ELTROXIN tablet 100 µg
- ELTROXIN tablet 50 µg
- J01 - Antibacterianos para uso sistémico
- CEPOREX capsule, hard 250 mg
- CEPOREX capsule, hard 500 mg
- CEPOREX powder for oral suspension 125 mg/5 ml
- CEPOREX powder for oral suspension 250 mg/5 ml
- ZINACEF powder for solution for injection 1.5 g
- ZINACEF powder for solution for injection 250 mg
- ZINACEF powder for solution for injection 750 mg
- ZINACEF solution for infusion 1.5 g
- ZINNAT tablet 125 mg
- ZINNAT tablet 250 mg
- ZINNAT tablet 500 mg
- J05 - Antivirales de uso sistémico
- ZIAGEN film-coated tablet 300 mg
- ZIAGEN oral solution 20 mg/ml
- N02 - Analgésicos
- IMIGRAN solution for injection 6 mg/0.5 ml
- IMIGRAN tablet 100 mg
- IMIGRAN tablet 50 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- FLIXOTIDE DISKUS inhalation powder 50 µg
- FLIXOTIDE pressurised inhalation, suspension 125 µg/dose
- FLIXOTIDE pressurised inhalation, suspension 25 µg/dose
- FLIXOTIDE pressurised inhalation, suspension 250 µg/dose
- FLIXOTIDE pressurised inhalation, suspension 50 µg/dose
- SEREVENT DISKUS inhalation powder 50 µg/dose
- VENTOLIN nebuliser solution 1.25 mg/2.5 ml
- VENTOLIN pressurised inhalation, suspension 100 µg/dose